Imipenem - Moligand™, ≥98% , CAS No.64221-86-9

CAS: 64221-86-9 Cat. No.: I304258 Formule: C12H17N3O4S Poids moléculaire: 299.34
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
(5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl}thio)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-, (5R,6S)-|1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-,(5R,6S)-|Tienamycin|1H-Isoindole-1,3(2H)-dione, 3a,4,7,7a-tetrahydro-2-[(trichloromethyl)thio]-|(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenen|Primaxin (imipenem + cilastatin)|IMIPENEM ANHYDRATE|Imipenem anhydrous|Imipemide|Imipenem, N-Formimidoyl thienamycin|N-1-Naphthyl-phthalamidsaeure [German]|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure|(5R,6S)-6-[(1R)-1-hydroxyethyl]-3-[(2-methanimidamidoethyl)sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|imipenem|IMIPENEM [MI]|Recarbrio (imipenem + cilastatin + relebactam).|1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R-(5-alpha,6-alpha(R*)))-|Pharmakon1600-01506001|(5R,6S)-6-[(1R)-1-hydroxyethyl]-3-(2-methanimidamidoethylsulfanyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|MK-0787|1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-((1R)-1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R,6S)-|1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID, 6-(1-HYDROXYETHYL)-3-((2-((IMINOMETHYL)AMINO)ETHYL)THIO)-7-OXO-, (5R-(5.ALPHA.,6.ALPHA.(R*)))-|Imipenem (INN)|Imipenem [INN]|Thienamycin p-nitrobenzylester hydrochloride(N-methylpyrrolidinonesolvate)|[5R-[5.alpha.,6.alpha.(R*)]]-6-(1-Hydroxyethyl)-3-[[2- [(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2- ene-2-carboxylic acid monohydrate|Imipenemum|(5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|MK 0787|MK-787|SDCCGSBI-0633697.P001|Anhydrous Imipenem|N,N-diethyl-2-[3-(1-phenylpropyl)-1,2,4-oxadiazol-5-yl]ethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid|Imipenemum [Latin]|(5R,6S)-3-((2-formimidamidoethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Uridine 5'-(trihydrogen diphosphate), P'-a-D-glucopyranosyl ester (9CI)|imipen|N-Formimidoylthienamycin|Imipenem, Anhydrous|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|IMIPENEM [WHO-DD]|(5R,6S)-3-(2-formimidamidoethylthio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Chryzotek
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Taille
USA
Allemagne (EU)*
Prix
Qté
100mg
I304258-100mg
1 En stock
—
89,90$US
250mg
I304258-250mg
1 En stock
—
159,90$US
1g
I304258-1g
1 En stock
—
496,90$US
Enter a quantity for the sizes you want to add.

Vue d’ensemble

Imipenem (MK0787), a stable crystalline derivative of thienamycin, is an antibiotic and has the excellent activity against a broad range of gram-positive and gram-negative aerobic and anaerobic bacteria. Imipenem can be used for the research of carbapenem-nonsusceptible and P. aeruginosa biofilm infections.

Spécifications

Synonymes
(5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl}thio)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid | 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-, (5R,6S)- | 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-3-[[2-[(imin Afficher plus
Spécifications et pureté
Moligand™, ≥98%
Mécanismes biochimiques et physiologiques
Highly potent, broad spectrum β-lactam antibiotic (IC 50 = 0.15 μM). Bactericidal effect and capable of interacting with GABA A receptors. Modest penetration of the BBB.
Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Grade
Moligand™
Type d'action
INHIBITOR
Note
Unstable; make up solutions fresh and use immediately. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Pureté
≥98%
Noms et identifiants
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488187374
SMILES
CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O
IUPAC Name
(5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
InChIKey
ZSKVGTPCRGIANV-ZXFLCMHBSA-N
InChI
1S/C12H17N3O4S/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19)/t6-,7-,9-/m1/s1
Isomères SMILES
C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O
Poids moléculaire
299.34
Reaxy-Rn
7596364
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=7596364&ln=

Données avancées

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClasseLactams
SubclassBeta lactams
Intermediate Tree Nodes Carbapenems
Direct ParentThienamycins
Alternative Parents Alpha amino acids and derivatives  Pyrroline carboxylic acids  Azepines  Vinylogous thioesters  Tertiary carboxylic acid amides  Thioenol ethers  Secondary alcohols  Azetidines  Sulfenyl compounds  Azacyclic compounds  Carboxamidines  Carboximidamides  Carboxylic acids  Monocarboxylic acids and derivatives  Formamidines  Carbonyl compounds  Organopnictogen compounds  Hydrocarbon derivatives  Imines  Organic oxides  
Molecular FrameworkAliphatic heteropolycyclic compounds
Substituents Thienamycin - Alpha-amino acid or derivatives - Pyrroline carboxylic acid - Pyrroline carboxylic acid or derivatives - Azepine - Vinylogous thioester - Pyrroline - Tertiary carboxylic acid amide - Azetidine - Carboxamide group - Secondary alcohol - Thioenolether - Sulfenyl compound - Carboximidamide - Azacycle - Amidine - Formamidine - Carboxylic acid amidine - Carboxylic acid derivative - Carboxylic acid - Monocarboxylic acid or derivatives - Hydrocarbon derivative - Imine - Organonitrogen compound - Organooxygen compound - Organosulfur compound - Carbonyl group - Alcohol - Organic oxygen compound - Organopnictogen compound - Organic oxide - Organic nitrogen compound - Aliphatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as thienamycins. These are beta-lactam antibiotics that differ from penicillins in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain.
External Descriptors carbapenems
Structure 3D
Modèle de structure chimique interactif





Cibles associées (humaines)
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC29A1 Tclin Equilibrative nucleoside transporter 1 (1711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2B Tclin Alpha-2b adrenergic receptor (4412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DPEP1 Tclin Renal dipeptidase (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRA Tclin Endothelin receptor ET-A (5008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNA4 Tclin Neuronal acetylcholine receptor protein alpha-4 subunit (1265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALB Tchem Serum albumin (2651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ARSA Tbio Cerebroside-sulfatase (655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cibles associées (non humaines)
bla Beta-lactamase TEM (457 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
mrcA Penicillin-binding protein 1A (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
mrdA Penicillin-binding protein 2 (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
mrcB Penicillin-binding protein 1B (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
blaZ Beta-lactamase (285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Schaalia meyeri (78 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus durans (113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella paratyphi (588 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus pneumoniae (31063 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus (1748 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus viridans (303 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Eggerthella lenta (139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter calcoaceticus subsp. anitratus (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacteria (550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Campylobacter jejuni (634 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Burkholderia cepacia (649 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas fluorescens (1630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas putida (467 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella enterica subsp. enterica serovar Typhi str. CT18 (145 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacter cloacae (7976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella (302 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Proteus (150 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Proteus vulgaris (5823 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Providencia rettgeri (925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Providencia sp. (46 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhimurium (15756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella flexneri (1836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella sp. (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Yersinia enterocolitica (166 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aeromonas sobria (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Haemophilus parainfluenzae (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pasteurella multocida (1166 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacteroides fragilis (1445 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacteroides thetaiotaomicron (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Parabacteroides distasonis (282 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Porphyromonas gingivalis (651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fusobacterium mortiferum (179 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fusobacterium varium (184 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fusobacterium necrophorum (183 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Peptoniphilus asaccharolyticus (368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Peptostreptococcus anaerobius (347 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Micrococcus luteus (7463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus haemolyticus (1695 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mécanismes d'action
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

30 results found

Lot NumberCertificate TypeDateArticle
I2620511I2620511Certificate of AnalysisAug 26, 2026 I304258
I2620532I2620532Certificate of AnalysisAug 26, 2026 I304258
I2620533I2620533Certificate of AnalysisAug 26, 2026 I304258
C23111113C23111113Certificate of AnalysisDec 10, 2025 I304258
C23111130C23111130Certificate of AnalysisDec 10, 2025 I304258
C23111132C23111132Certificate of AnalysisDec 10, 2025 I304258
G2516305G2516305Certificate of AnalysisJun 28, 2025 I304258
H2631046H2631046Certificate of AnalysisJun 28, 2025 I304258
G2516304G2516304Certificate of AnalysisJun 28, 2025 I304258
G2516303G2516303Certificate of AnalysisJun 28, 2025 I304258
K2421441K2421441Certificate of AnalysisNov 11, 2024 I304258
K2421442K2421442Certificate of AnalysisNov 11, 2024 I304258
K2421443K2421443Certificate of AnalysisNov 11, 2024 I304258
I2402157I2402157Certificate of AnalysisAug 21, 2024 I304258
I2402158I2402158Certificate of AnalysisAug 21, 2024 I304258
I2402159I2402159Certificate of AnalysisAug 21, 2024 I304258
E2429418E2429418Certificate of AnalysisApr 24, 2024 I304258
E2429409E2429409Certificate of AnalysisApr 24, 2024 I304258
E2429401E2429401Certificate of AnalysisApr 24, 2024 I304258
K2324441K2324441Certificate of AnalysisOct 21, 2023 I304258
K2324432K2324432Certificate of AnalysisOct 21, 2023 I304258
C23111107C23111107Certificate of AnalysisFeb 25, 2023 I304258
C23111115C23111115Certificate of AnalysisFeb 25, 2023 I304258
I2207652I2207652Certificate of AnalysisJul 22, 2022 I304258
I2207651I2207651Certificate of AnalysisJul 22, 2022 I304258
J2313139J2313139Certificate of AnalysisJul 22, 2022 I304258
I2207650I2207650Certificate of AnalysisJul 22, 2022 I304258
H2325044H2325044Certificate of AnalysisJul 22, 2022 I304258
H2325043H2325043Certificate of AnalysisJul 22, 2022 I304258
C2226653C2226653Certificate of AnalysisMay 24, 2022 I304258
Propriétés chimiques et physiques
Poids moléculaire299.350 g/mol
XLogP3-0.700
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass299.094 Da
Monoisotopic Mass299.094 Da
Topological Polar Surface Area142.000 Ų
Heavy Atom Count20
Formal Charge0
Complexity491.000
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
FAQ et articles
Citations of This Product
Calculateurs de solution
Avis

Avis des clients

Application Protocols

Validated, product-specific protocols and recommended parameters for this SKU are Not specified for this item; refer to CoA/Spec Sheet.

Usage notes (general, non-validated guidance)

  • Stock preparation: Prepare fresh aqueous stock in cold, sterile water or mildly acidic buffer. Filter through 0.22 µm if sterility is required. Aliquot to minimize freeze–thaw.
  • Handling during assays: Keep on ice prior to initiation; limit time at room temperature. For long assays, consider staged additions to compensate for decay.
  • Quantification: Use stability-indicating HPLC/LC–MS methods; include an internal standard and immediate t0 samples for accurate concentration assignment.

Please treat the above as general guidance only; establish and validate conditions in your own lab.

Biological Roles

General biochemical role (literature)

  • Target class: Bacterial penicillin-binding proteins (PBPs), the transpeptidases responsible for peptidoglycan crosslinking.
  • Mechanism: The beta-lactam acts as an acylating agent of the catalytic serine in PBPs, forming a covalent acyl-enzyme intermediate with slow deacylation, thereby blocking cell wall crosslinking.
  • Spectrum context: Carbapenems typically display broad target engagement across multiple PBPs in Gram-positive and Gram-negative bacteria, though permeability and efflux differ by species.
  • Resistance mechanisms studied with this probe: Carbapenemase-mediated hydrolysis (e.g., KPC, NDM, OXA enzymes), altered porin influx, efflux pump overexpression, and PBP mutations.

Physicochemical drivers of biology

  • Zwitterionic nature enhances aqueous diffusion and, in some organisms, porin-mediated uptake. The strained beta-lactam ring is essential for acylation reactivity, while side-chain stereochemistry modulates PBP selectivity.

Experimental considerations

  • Assay design often employs buffered aqueous media at mildly acidic pH to slow non-enzymatic hydrolysis while preserving PBP interactions.
  • Hydrolysis products (ring-opened species) are commonly monitored by LC–MS as part of stability-indicating methods.

Notes

  • This section describes mechanistic/biochemical properties of the compound in research settings. No medical or clinical claims are implied or intended.
Buffer Applications

Applicability: As a zwitterionic, water-soluble beta-lactam used in biochemical assays, buffer selection is central to reliable use.

General guidance (literature/practice)

  • Preferred pH: Mildly acidic buffers (e.g., pH ~5.5–6.5) such as sodium acetate or citrate can improve solution stability versus neutral/alkaline conditions.
  • Ionic strength: Keep minimal salt necessary for activity/stability; excessive ionic strength is usually not required and may complicate downstream analysis.
  • Sterility: If sterility is required, prepare under aseptic conditions and filter through 0.22 µm membranes. Avoid heat sterilization, which accelerates degradation.
  • Compatibility: Avoid buffers with strong nucleophilic components or amines at high pH that could accelerate beta-lactam opening.

Example preparation (illustrative; not item-specific specifications)

  • Make a fresh stock solution in cold, degassed water or 10–50 mM acetate buffer at pH ~6.0. Vortex gently to dissolve; use immediately or aliquot and freeze.

Item-specific buffering recommendations (pH ranges, excipients, stabilizers): Not specified for this item; refer to CoA/Spec Sheet.

Green Alternatives

This product is a bioactive small molecule used as a research tool, not a process solvent or bulk reagent. “Green alternatives” are therefore less about solvent replacement and more about minimizing waste and degradation byproducts.

Context and options (general guidance)

  • Reduce waste by preparing only the quantity of aqueous solution needed for the immediate experiment; imipenem degrades in solution, so oversized preparations increase chemical waste.
  • Choose greener buffers: Acetate or citrate buffers at low concentrations can be preferable to nonvolatile salts when downstream lyophilization or MS analysis is required.
  • Analytical methods: Favor LC–MS-compatible mobile phases (water–acetonitrile with low-percentage formic acid) to avoid phosphate waste; use shorter columns and lower flow rates to reduce solvent consumption.

Comparative perspective

  • Alternative research probes for PBP inhibition (e.g., penicillins, cephalosporins) may offer improved stability in neutral media, potentially reducing the need for repeated solution preparation. Trade-off: different target engagement profiles and resistance liabilities.

Note

  • No process-scale substitution guidance applies here. Item-specific environmental metrics (e.g., E-factor, LCI): Not specified for this item; refer to CoA/Spec Sheet.
Pharmaceutical Uses

Scope: The information below is provided only in the context of research, development, and analytical/formulation science. This SKU is for research use only and is not intended for human or veterinary use.

Research/formulation roles (general)

  • Preformulation studies: Evaluate solid-state forms (hydrate state, polymorphism), aqueous stability across pH, and degradation kinetics to inform formulation science.
  • Reference standard: Analytical standard for method development and validation (e.g., HPLC assay, LC–MS impurity/degradant profiling) in beta-lactam projects.
  • Compatibility screening: Excipient compatibility and pH–stability mapping in model systems; exploration of lyophilization cycles for stability enhancement (research only).
  • Degradation pathway elucidation: Identification and quantitation of ring-opened species and secondary degradants under ICH-like stress conditions (acid/base, thermal, oxidative, photolytic), strictly for laboratory investigation.

Item-specific pharmacopeial status, residual solvent limits, and GMP suitability: Not specified for this item; refer to CoA/Spec Sheet.

Physical Properties

Item-specific (Product Data)

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Literature/General properties (for reference only; verify for the supplied form)

  • Physical state: Solid; carbapenems commonly appear as off-white to pale solids (literature)
  • Melting behavior: Decomposes on heating; sharp melting point is not typically reported due to beta-lactam instability (literature)
  • Solubility: High aqueous solubility; freely soluble in water and many aqueous buffers; poor solubility in nonpolar organic solvents (literature)
  • Acid–base character: Zwitterionic; carboxylate acidic and amidine/basic center; overall net charge depends on pH (literature)
  • Partitioning: Expected low logP/logD at neutral pH due to zwitterionic character (literature)
  • Stability in solution: Hydrolyzes in neutral to alkaline conditions via beta-lactam ring opening; improved stability in mildly acidic media (literature)

Practical implications

  • Prepare aqueous solutions shortly before use; minimize exposure to elevated temperature and neutral/basic pH.
  • When quantitating, use rapid HPLC methods with chilled autosampler to limit on-instrument degradation.

Authoritative values for BP/MP, density, refractive index, pKa, logP, UV cutoff, residuals: Not specified for this item; refer to CoA/Spec Sheet.

Quality and Grades

Item-specific

  • Grade/Purity designation: Moligand™ (as provided by Aladdin Scientific)

What Moligand™ typically implies (general guidance)

  • The Moligand™ line is intended for research use in molecular recognition, target engagement, screening, and mechanistic enzymology. For small-molecule ligands like imipenem, emphasis is generally placed on identity confirmation and suitability for binding/enzymology assays (e.g., LC–MS/NMR identity and purity screening, low residual inorganic salts where relevant). Exact specifications vary by SKU and batch.

Important clarifications for this item

  • Exact purity assay method, residual solvent/metal limits, water content, counterion/hydrate state, stabilizers, and UV profile: Not specified for this item; refer to CoA/Spec Sheet.
  • Regulatory/compendial status: This listing is for research use only (non-GMP, non-clinical). Not intended for human or veterinary use.

Best practices for quality-sensitive applications

  • Request and review the batch CoA for: assay purity (HPLC/UPLC), structural confirmation (1H/13C NMR or HRMS), residual solvents, water content (KF), and any stabilizers or buffering salts.
  • For quantitative microbiology/enzymology, establish an in-house reference curve and verify potency immediately after reconstitution due to known hydrolytic lability of carbapenems.
Reaction and Applications

This molecule is primarily used as a biochemical tool compound rather than as a synthetic solvent or reagent.

Research applications (literature/general)

  • Target engagement studies: Probe for penicillin-binding proteins (PBPs) in bacterial membrane preparations; used to benchmark PBP inhibition in biochemical assays.
  • Enzyme kinetics: Substrate/inhibitor in beta-lactamase assays to measure hydrolysis rates, inhibition by beta-lactamase inhibitors, or to profile carbapenemase activity.
  • Microbial susceptibility research: Establish MIC/MBC values in vitro for method development and resistance mechanism studies (non-clinical, research-only context).
  • Analytical reference: Standard for HPLC/LC–MS method development in beta-lactam analysis, degradation pathway mapping (e.g., ring-opened products), and impurity profiling.

Mechanistic notes (general)

  • Inactivates PBPs via acylation of the active-site serine; slow deacylation yields prolonged inhibition. Hydrolysis by carbapenemases restores enzyme activity.
  • Hydrolytic lability of the beta-lactam dictates handling: cooler temperatures, mildly acidic media, and rapid analysis improve reproducibility.

Practical tips

  • Prepare fresh aqueous solutions immediately before use; filter-sterilize through 0.22 µm if sterility is required.
  • Avoid buffers above neutral pH; use pre-chilled solutions and keep assay plates on ice until initiation.
  • For kinetics, determine time-zero concentrations by back-calculation from immediate injection samples (t0) to account for on-bench degradation.

Item-specific tested applications: Not specified for this item; refer to CoA/Spec Sheet.

Reaction Conditions

This product functions primarily as a biochemical tool rather than a reagent for preparative organic synthesis. Accordingly, “reaction conditions” are mostly relevant to enzymology and degradation studies.

General assay/degradation conditions (literature)

  • Enzyme kinetics with beta-lactamases: Aqueous buffers (e.g., 50 mM phosphate or HEPES) at pH 7.0–7.5 and 25–37 °C are common for characterizing hydrolysis; continuous spectrophotometric or LC–MS readouts quantify turnover. Note: stability decreases as pH and temperature rise.
  • Stability assessment: Forced degradation at controlled pH (acidic vs neutral vs basic) and temperature (e.g., 25–60 °C) to map pathways; quench immediately (acidify and chill) before analysis.
  • HPLC analysis: Reversed-phase C18 with water–acetonitrile (0.05–0.1% formic acid) at low column temperatures (e.g., 20 °C) can improve peak shape and reduce on-column degradation.

Practical tips

  • Prepare substrate/inhibitor solutions on ice; initiate assays promptly.
  • Use matched blanks to correct for non-enzymatic decay.

Item-specific, validated reaction/assay conditions for this SKU: Not specified for this item; refer to CoA/Spec Sheet.

Safety and Handling

Authoritative hazard information for this specific item (GHS classification, pictograms, H-statements, signal word): Not specified for this item; refer to the product SDS.

General laboratory safety guidance (literature/commonsense for beta-lactams)

  • Sensitization potential: Beta-lactams can cause allergic sensitization. Avoid inhalation of dust and skin exposure. Use closed handling where feasible.
  • PPE: Lab coat, nitrile gloves (double-gloving recommended for sensitizers), safety glasses or face shield when handling powders/solutions; work in a chemical fume hood or biosafety cabinet as appropriate.
  • Avoid: Aerosol generation; contact with strong bases or nucleophiles (accelerates beta-lactam hydrolysis); prolonged exposure to elevated temperatures.
  • First aid (general): In case of skin contact, wash thoroughly with soap and water. If inhaled, move to fresh air. For eye contact, rinse cautiously with water for several minutes and seek medical attention. If ingested, rinse mouth and seek medical attention. Always follow your institution’s protocols.
  • Spill/cleanup: Avoid raising dust. Gently sweep/HEPA vacuum and wipe with damp disposable towels; dispose as hazardous chemical waste. Decontaminate surfaces with aqueous acidic detergent, avoiding strong base.
  • Fire response: Not known to be highly flammable as a solid; use water fog, CO2, dry chemical, or foam. Thermal decomposition may release nitrogen/sulfur-containing fumes.

Storage incompatibilities

  • Incompatible with strong bases, strong nucleophiles, and prolonged exposure to moisture/neutral-to-basic aqueous media. Store segregated from amines and reducing agents.

Defer to the SDS for definitive guidance for this SKU.

Solvent Selection

Imipenem is a polar, zwitterionic beta-lactam; solvent choice is dominated by aqueous compatibility and hydrolytic stability.

Polarity and miscibility (literature/general)

  • Highly water-soluble; solutions can be prepared in deionized water or mildly acidic aqueous buffers.
  • Poorly soluble in most aprotic/nonpolar organics (e.g., hexanes, toluene, ethers). Limited solubility in alcohols; tends to degrade in basic alcohols over time.

Practical solvent choices by use case

  • Enzymology/microbiology assays: Use cold water or buffer adjusted to mildly acidic pH (e.g., acetate, citrate). Prepare fresh; keep on ice to limit beta-lactam hydrolysis.
  • Chromatographic workups: Use water-containing mobile phases. For reversed-phase HPLC, include a volatile acid (e.g., 0.05–0.1% formic acid) for sharper peaks and improved stability during analysis.
  • Stock solutions: Aqueous stock at 10–50 mM prepared immediately before use. For longer-term aliquots, freeze at −20 °C to −80 °C; avoid alkaline pH.

When to choose alternatives

  • If organic-solvent compatibility is required, this compound is not ideal. Consider more hydrophobic beta-lactams or prodrug derivatives for organic-phase studies. For stability-critical screens, evaluate carbapenems reported to have improved solution half-life in neutral media (literature), acknowledging mechanistic differences.

Notes

  • Exact solubility limits, preferred buffer identity/pH, and cosolvent tolerances for this SKU: Not specified for this item; refer to CoA/Spec Sheet.
Storage and Reconstitution

Item-specific (from Product Data)

  • Storage conditions: Store at -20°C.
  • Shipped in: Ice chest + Ice pads.
  • Research use note: For research use only.

General handling and reconstitution (literature/practice)

  • Solid storage: Protect from light and moisture. Keep container tightly closed under inert headspace if possible. Allow to warm to room temperature in a desiccator before opening to minimize condensation.
  • Reconstitution: Dissolve in cold sterile water or mildly acidic buffer (e.g., acetate, pH ~6). Mix gently; avoid strong base or prolonged vortexing/warming.
  • Aliquoting: Immediately dispense single-use aliquots; freeze at −20 to −80 °C. Avoid repeated freeze–thaw cycles that can accelerate degradation.
  • In-use stability: Expect limited stability in neutral aqueous media at ambient temperature; prepare just-in-time for experiments and keep on ice until use.

Item-specific details such as maximum concentration, exact pH range for optimal stability, presence of stabilizers, solution shelf life at given temperatures: Not specified for this item; refer to CoA/Spec Sheet.

Structure and Identity

Overview: Imipenem is a carbapenem-class beta-lactam containing a bicyclic fused beta-lactam ring system, used widely as a research-standard inhibitor of bacterial cell wall transpeptidases (PBPs).

Item-specific (from Product Data)

  • SKU: I304258
  • Product name: Imipenem
  • CAS: 64221-86-9
  • InChIKey: 465364 (as provided)
  • Grade/Purity: Moligand™

Literature/General structural information (for reference; verify exact form against the item’s CoA)

  • Common identity: Imipenem (anhydrous base)
  • Typical molecular formula (literature): C12H17N3O4S (anhydrous)
  • Typical molecular weight (literature): ~299.35 g/mol (anhydrous); common hydrate forms exist
  • Representative SMILES (literature, imipenem base): O=C1NC@HC(=C[S@@H]1CC@HC(=N)N)C
  • Key functional groups: beta-lactam (azetidinone), carboxylate, secondary alcohol, amidine/iminocarboxamide moiety, thioether bridge (carbapenem core)
  • Stereochemistry: Multiple defined stereocenters in the carbapenem core (configuration critical to activity); literature assignments at C5/C6 of the beta-lactam-fused system

2D description in words (general)

  • A four-membered beta-lactam ring is fused to an unsaturated five-membered ring (carbapenem). A carboxylate substituent projects from the beta-lactam carbonyl-bearing carbon; the fused ring bears a thio-substituted bridge and a hydroxyethyl side chain. The terminal amino functionality is present as an imino-derived amidine (commonly protonated), rendering the molecule zwitterionic in water.

Notes

  • Exact salt/hydrate state and identifiers for this specific item are Not specified for this item; refer to CoA/Spec Sheet.
Synthetic Utility

Imipenem is a complex, highly functionalized carbapenem; it is not commonly used as a synthetic building block. However, it has value in synthesis-adjacent research contexts.

Utility in synthesis and analysis (general)

  • Mechanistic probe: Covalent acylation of serine nucleophiles provides a benchmark for studying acyl-transfer mechanisms in enzyme models and small-molecule surrogates.
  • Degradation chemistry: Controlled hydrolysis and derivatization of the ring-opened products enable mapping of beta-lactam reactivity and designing stability-indicating analytical methods.
  • Chiral/stereochemical reference: Multiple stereocenters and a strained bicyclic system make it a reference for chiroptical and NMR-based stereochemical assignment methodologies.

Transformations (literature/observations)

  • Base- or enzyme-catalyzed beta-lactam ring opening to form corresponding carboxylate/amine derivatives.
  • N-derivatization of the amidine functionality under carefully controlled, mild conditions for analytical tagging (e.g., dansylation/fluorogenic labeling in trace analytics), acknowledging potential loss of activity.

Caveats

  • The molecule’s lability and functional density limit its practicality as a synthetic intermediate. If chemical modification is required, employ low temperatures, short reaction times, and buffered, mildly acidic aqueous/organic biphasic systems.

Item-specific reactivity specs or impurity constraints: Not specified for this item; refer to CoA/Spec Sheet.

Target Specificity

This section typically applies to biologics (e.g., antibodies) with defined antigen/epitope specificity. For a small-molecule like imipenem, classic antigen/epitope fields (species reactivity, clone, isotype) are not applicable.

Item-specific target data: Not specified for this item; refer to CoA/Spec Sheet.

General biochemical context (literature)

  • Molecular target class: Penicillin-binding proteins (PBPs; serine transpeptidases) in bacterial cell wall biosynthesis.
  • Off-target considerations: Susceptible to hydrolysis by beta-lactamases/carbapenemases; non-enzymatic hydrolysis in solution is a major confounder in target engagement studies.

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.